American Healthcare REIT, Inc. (AHR)
(Delayed Data from NYSE)
$14.07 USD
+0.07 (0.50%)
Updated May 28, 2024 04:00 PM ET
After-Market: $14.05 -0.02 (-0.14%) 7:58 PM ET
3-Hold of 5 3
B Value D Growth C Momentum C VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
AHR 14.07 +0.07(0.50%)
Will AHR be a Portfolio Killer in May?
Zacks Investment Research is releasing its prediction for AHR based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for AHR
Implied Volatility Surging for American Healthcare (AHR) Stock Options
Is a Surprise Coming for American Healthcare (AHR) This Earnings Season?
AHR: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for AHR
Analysts Offer Insights on NA Companies: Rubrik, Inc. Class A (RBRK) and American Healthcare REIT, Inc. (AHR)
Surprise Spring Slowdown
Unveiling 11 Analyst Insights On American Healthcares
American Healthcare REIT: Balanced Operational Strength and Strategic Portfolio Management Amid Cautious Hold Rating
JMP Securities Sticks to Their Buy Rating for American Healthcare REIT, Inc. (AHR)